Clinical Exploration of NEUROMARK System in Participants With Chronic Migraine
Completed · Not applicable · NCT06862674
Conditions: Chronic Migraine Headache
At a glance
- Research payments reported, 2025
- $98,309
- U.S. investigators named
- 0
- Sites paid
- 0
- Planned or actual enrollment
- 24
About the trial
- Sponsor
- Neurent Medical
- Tested
- NEUROMARK System (device)
- Dates
- Started 2024-09-06; completion 2026-01-21
- Results posted
- Not yet
Clinical exploration of NEUROMARK System in Participants with Chronic Migraine
From ClinicalTrials.gov, last updated 2026-09-16. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Neurent Medical Limited reported $98,309 in research payments for this study in 2025 (22 payments).
Products named: Neuromark System, Neuromark Radiofrequency Console
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
Sites paid to run it
- $98,309
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.